ARCHIVES

DCT Advisors Approve Grants Program For Trials Of BRMs

This article is from The Cancer Letter archive.

Vol. 21 No. 10 | March 10, 1995

Download PDF Visit The Full Archive

Related Articles

MAP Says It Will Continue Operating With Private Funds

April 18, 1986

Four DCCP Contracts Costing $9 Million Approved By Board for Recompetition

June 10, 1983

Wyden Compared Taxol To AZT; But Experts Note Lack Of Patent

August 9, 1991

Propac To Recommend Reclassification Of Five Leukemia/Lymphoma Diagnosis Related Groups

March 21, 1986

Oxaliplatin Added To 5-FU/LV Improves Disease-Free Survival In Early Colon Cancer

June 24, 2005

Owens Becomes President, NCCR

June 21, 1996